{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:21:31Z","timestamp":1783704091776,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004972","name":"Maryland Industrial Partnerships","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12028-020-01044-9","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T18:03:38Z","timestamp":1594749818000},"page":"500-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety and Feasibility of a Novel Transnasal Cooling Device to Induce Normothermia in Febrile Cerebrovascular Patients"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-9034","authenticated-orcid":false,"given":"Neeraj","family":"Badjatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Haymore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemantkumar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishna","family":"Tandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146\u2013e603.","journal-title":"Circulation"},{"key":"1044_CR2","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1161\/STROKEAHA.108.521583","volume":"39","author":"DM Greer","year":"2008","unstructured":"Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke. 2008;39:3029\u201335.","journal-title":"Stroke"},{"key":"1044_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12028-011-9588-6","volume":"15","author":"V Scaravilli","year":"2011","unstructured":"Scaravilli V, Tinchero G, Citerio G. Participants in the international multi-disciplinary consensus conference on the Critical Care Management of Subarachnoid H. Fever management in SAH. Neurocrit Care. 2011;15:287\u201394.","journal-title":"Neurocrit Care"},{"key":"1044_CR4","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013e418.","journal-title":"Stroke"},{"key":"1044_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/B978-0-444-64074-1.00049-5","volume":"157","author":"R Gowda","year":"2018","unstructured":"Gowda R, Jaffa M, Badjatia N. Thermoregulation in brain injury. Handb Clin Neurol. 2018;157:789\u201397.","journal-title":"Handb Clin Neurol"},{"key":"1044_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/ther.2017.0033","volume":"8","author":"I Khan","year":"2018","unstructured":"Khan I, Haymore J, Barnaba B, et al. Esophageal cooling device versus other temperature modulation devices for therapeutic normothermia in subarachnoid and intracranial hemorrhage. Ther Hypothermia Temp Manag. 2018;8:53\u20138.","journal-title":"Ther Hypothermia Temp Manag"},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1097\/01.CCM.0000147441.39670.37","volume":"32","author":"SA Mayer","year":"2004","unstructured":"Mayer SA, Kowalski RG, Presciutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004;32:2508\u201315.","journal-title":"Crit Care Med"},{"key":"1044_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/01.CCM.0000108868.97433.3F","volume":"32","author":"MN Diringer","year":"2004","unstructured":"Diringer MN. Neurocritical care fever reduction trial G. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004;32:559\u201364.","journal-title":"Crit Care Med"},{"key":"1044_CR9","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1097\/00003246-200211000-00013","volume":"30","author":"E Schmutzhard","year":"2002","unstructured":"Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med. 2002;30:2481\u20138.","journal-title":"Crit Care Med"},{"key":"1044_CR10","doi-asserted-by":"publisher","first-page":"105412","DOI":"10.1016\/j.clineuro.2019.105412","volume":"184","author":"SA Griffiths","year":"2019","unstructured":"Griffiths SA, Ahmad J, Francoeur CL, et al. The EMCOOLs surface cooling system for fever control in neurocritical care patients: a pilot study. Clin Neurol Neurosurg. 2019;184:105412.","journal-title":"Clin Neurol Neurosurg"},{"key":"1044_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12028-007-0011-2","volume":"6","author":"N Badjatia","year":"2007","unstructured":"Badjatia N, Kowalski RG, Schmidt JM, et al. Predictors and clinical implications of shivering during therapeutic normothermia. Neurocrit Care. 2007;6:186\u201391.","journal-title":"Neurocrit Care"},{"key":"1044_CR12","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1161\/STROKEAHA.108.523654","volume":"39","author":"N Badjatia","year":"2008","unstructured":"Badjatia N, Strongilis E, Gordon E, et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke. 2008;39:3242\u20137.","journal-title":"Stroke"},{"key":"1044_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00000542-200202000-00036","volume":"96","author":"J De Witte","year":"2002","unstructured":"De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology. 2002;96:467\u201384.","journal-title":"Anesthesiology"},{"key":"1044_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12028-007-9015-1","volume":"9","author":"JS Hata","year":"2008","unstructured":"Hata JS, Shelsky CR, Hindman BJ, Smith TC, Simmons JS, Todd MM. A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury. Neurocrit Care. 2008;9:37\u201344.","journal-title":"Neurocrit Care"},{"key":"1044_CR15","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1161\/STROKEAHA.116.014200","volume":"47","author":"P Lyden","year":"2016","unstructured":"Lyden P, Hemmen T, Grotta J, et al. Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke. 2016;47:2888\u2013955.","journal-title":"Stroke"},{"key":"1044_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12028-009-9280-2","volume":"12","author":"M Oddo","year":"2010","unstructured":"Oddo M, Frangos S, Maloney-Wilensky E, Andrew Kofke W, Le Roux PD, Levine JM. Effect of shivering on brain tissue oxygenation during induced normothermia in patients with severe brain injury. Neurocrit Care. 2010;12:10\u20136.","journal-title":"Neurocrit Care"},{"key":"1044_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4037\/ccn2012189","volume":"32","author":"M Presciutti","year":"2012","unstructured":"Presciutti M, Bader MK, Hepburn M. Shivering management during therapeutic temperature modulation: nurses' perspective. Crit Care Nurse. 2012;32:33\u201342.","journal-title":"Crit Care Nurse"},{"key":"1044_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12028-013-9948-5","volume":"21","author":"AS Lord","year":"2014","unstructured":"Lord AS, Karinja S, Lantigua H, et al. Therapeutic temperature modulation for fever after intracerebral hemorrhage. Neurocrit Care. 2014;21:200\u20136.","journal-title":"Neurocrit Care"},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1385\/NCC:1:2:145","volume":"1","author":"N Badjatia","year":"2004","unstructured":"Badjatia N, O'Donnell J, Baker JR, et al. Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter. Neurocrit Care. 2004;1:145\u201356.","journal-title":"Neurocrit Care"},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12028-010-9474-7","volume":"14","author":"HA Choi","year":"2011","unstructured":"Choi HA, Ko SB, Presciutti M, et al. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care. 2011;14:389\u201394.","journal-title":"Neurocrit Care"},{"key":"1044_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1089\/ther.2018.0014","volume":"9","author":"FR Assis","year":"2019","unstructured":"Assis FR, Bigelow MEG, Chava R, et al. Efficacy and safety of transnasal CoolStat cooling device to induce and maintain hypothermia. Ther Hypothermia Temp Manag. 2019;9:108\u201317.","journal-title":"Ther Hypothermia Temp Manag"},{"key":"1044_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s12028-017-0469-5","volume":"27","author":"LK Madden","year":"2017","unstructured":"Madden LK, Hill M, May TL, et al. The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society. Neurocrit Care. 2017;27:468\u201387.","journal-title":"Neurocrit Care"},{"key":"1044_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12028-011-9506-y","volume":"14","author":"S Jarrah","year":"2011","unstructured":"Jarrah S, Dziodzio J, Lord C, et al. Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice. Neurocrit Care. 2011;14:382\u20138.","journal-title":"Neurocrit Care"},{"key":"1044_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/ther.2016.0016","volume":"7","author":"R Chava","year":"2017","unstructured":"Chava R, Zviman M, Raghavan MS, et al. Rapid induction of therapeutic hypothermia using transnasal high flow dry air. Therap Hypothermia Temp Manag. 2017;7:50\u20136.","journal-title":"Therap Hypothermia Temp Manag"},{"key":"1044_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/CIRCULATIONAHA.109.931691","volume":"122","author":"M Castren","year":"2010","unstructured":"Castren M, Nordberg P, Svensson L, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010;122:729\u201336.","journal-title":"Circulation"},{"key":"1044_CR26","doi-asserted-by":"publisher","first-page":"e4692","DOI":"10.1097\/MD.0000000000004692","volume":"95","author":"MS Grave","year":"2016","unstructured":"Grave MS, Sterz F, Nurnberger A, et al. Safety and feasibility of the RhinoChill immediate transnasal evaporative cooling device during out-of-hospital cardiopulmonary resuscitation: a single-center, observational study. Medicine (Baltimore). 2016;95:e4692.","journal-title":"Medicine (Baltimore)"},{"key":"1044_CR27","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.resuscitation.2016.01.036","volume":"103","author":"S Harris","year":"2016","unstructured":"Harris S, Bansbach J, Dietrich I, Kalbhenn J, Schmutz A. RhinoChill((R))-more than an \"ice-cream headache (1)\" serious adverse event related to transnasal evaporative cooling. Resuscitation. 2016;103:e5\u2013e6.","journal-title":"Resuscitation"},{"key":"1044_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12028-019-00702-x","volume":"31","author":"WC Ziai","year":"2019","unstructured":"Ziai WC, Shah D, Assis FR, Tandri H, Geocadin RG. Feasibility and safety of transnasal high flow air to reduce core body temperature in febrile neurocritical care patients: a pilot study. Neurocrit Care. 2019;31:280\u20137.","journal-title":"Neurocrit Care"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-01044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-020-01044-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-01044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:50:35Z","timestamp":1626220235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-020-01044-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-01044-9","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"14 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Harikrishna Tandri is the founder of CoolTech LLC, which is developing a transnasal device for hypothermia. The other authors report no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the University of Maryland, Baltimore Institutional Review Board. Informed consent for participation in the study was obtained from the legally authorized representative for each study patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}